|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 515/22 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 31/4995 | (2006.01) |
| (11) | Number of the document | 3395820 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18382287.3 |
| Date of filing the European patent application | 2018-04-27 | |
| (97) | Date of publication of the European application | 2018-10-31 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-15 |
| (46) | Date of publication of the claims translation | 2019-08-12 |
| (30) | Number | Date | Country code |
| 17382228 | 2017-04-27 | EP | |
| 17382497 | 2017-07-26 | EP |
| (72) |
CUEVAS MARCHANTE, Maria del Carmen, ES
FRANCESCH SOLLOSO, Andrés, ES
MARTINEZ BARRASA, Valentin, ES
|
| (73) |
Pharma Mar, S.A.,
Avenida de los Reyes, 1 Pol gono Industrial La Mina, 28770 Colmenar Viejo, Madrid,
ES
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Priešnavikiniai junginiai |
| ANTITUMORAL COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-04-01 | 8 | 185.00 EUR |
| 2026-04-27 |